Matches in SemOpenAlex for { <https://semopenalex.org/work/W36202033> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W36202033 endingPage "563" @default.
- W36202033 startingPage "563" @default.
- W36202033 abstract "563 Objectives Neuroendocrine tumors (NETs) are rare malignancies originating from neural crest cells throughout the body. 18F-FDG PET/CT is known to have limited role in NET detection. Data of 18F-DOPA PET/CT on NET have been mostly reported by the Western countries. We aimed to evaluate the incremental value of dual-tracer (18F-FDG and 18F-DOPA) PET/CT to 18F-DOPA alone in the assessment of NET in Asian patients. Methods Patients with known or suspected NETs referred for PET/CT during year 2007~10 were retrospectively reviewed and those with histopathological confirmation before or after PET/CT within 2 months or with uneventful findings upon serial PET/CT within 6 months were recruited into this study. All patients underwent two-day protocol of 18F-FDG and 18F-DOPA PET/CT within 1 week. Pre-medication with Carbidopa (200 mg) was given orally 60 minutes before 18F-DOPA injection. Whole-body PET/CT was performed 60 minutes after tracer injection and PET/CT images were reviewed by 3 nuclear medicine physicians in consensus. Results 26 patients (M: 16, F: 10, mean age: 53±18.3 years) with/without treatment (untreated: 12, treated: 14) before PET/CT were evaluated. Histopathological results confirmed NETs in 23 patients with primary sites at adrenal gland (N=4), rectum (3), colon (2), stomach (1), pancreas (4), appendix (1), urinary bladder (1), thyroid (1), neck (1) and unknown primary with hepatic NET metastases (5). 18F-DOPA PET/CT was true positive in 16/23 and false negative (FN) in 7/23. Of the 7 FN patients, 18F-FDG PET/CT was able to detect 4/7: pancreas (2), rectum (1) and liver (1). Therefore the sensitivity of 18F-DOPA alone versus dual-tracer PET/CT was 70% (16/23) versus 87% (20/23), respectively. The remaining 3 FN patients all had very small colonic carcinoid lesions (2mm, 3mm and 6mm). For the 3 negative patients confirmed by serial PET/CT, both 18F-DOPA and 18F-FDG PET/CT showed true negative findings (specificity: 100%). Conclusions Dual-tracer PET/CT has an incremental value to 18F-DOPA alone in increasing the detection sensitivity for NET patients" @default.
- W36202033 created "2016-06-24" @default.
- W36202033 creator A5000543654 @default.
- W36202033 creator A5013587526 @default.
- W36202033 creator A5018862176 @default.
- W36202033 creator A5024160874 @default.
- W36202033 creator A5032220397 @default.
- W36202033 creator A5078228793 @default.
- W36202033 creator A5083547822 @default.
- W36202033 date "2011-05-01" @default.
- W36202033 modified "2023-09-24" @default.
- W36202033 title "Dual-tracer (18F-FDG and 18F-DOPA) PET/CT in evaluation of neuroendocrine tumors: An Asian study" @default.
- W36202033 hasPublicationYear "2011" @default.
- W36202033 type Work @default.
- W36202033 sameAs 36202033 @default.
- W36202033 citedByCount "0" @default.
- W36202033 crossrefType "journal-article" @default.
- W36202033 hasAuthorship W36202033A5000543654 @default.
- W36202033 hasAuthorship W36202033A5013587526 @default.
- W36202033 hasAuthorship W36202033A5018862176 @default.
- W36202033 hasAuthorship W36202033A5024160874 @default.
- W36202033 hasAuthorship W36202033A5032220397 @default.
- W36202033 hasAuthorship W36202033A5078228793 @default.
- W36202033 hasAuthorship W36202033A5083547822 @default.
- W36202033 hasConcept C126322002 @default.
- W36202033 hasConcept C126838900 @default.
- W36202033 hasConcept C127077266 @default.
- W36202033 hasConcept C2775842073 @default.
- W36202033 hasConcept C2778764654 @default.
- W36202033 hasConcept C2779066768 @default.
- W36202033 hasConcept C2781074409 @default.
- W36202033 hasConcept C2989005 @default.
- W36202033 hasConcept C71924100 @default.
- W36202033 hasConceptScore W36202033C126322002 @default.
- W36202033 hasConceptScore W36202033C126838900 @default.
- W36202033 hasConceptScore W36202033C127077266 @default.
- W36202033 hasConceptScore W36202033C2775842073 @default.
- W36202033 hasConceptScore W36202033C2778764654 @default.
- W36202033 hasConceptScore W36202033C2779066768 @default.
- W36202033 hasConceptScore W36202033C2781074409 @default.
- W36202033 hasConceptScore W36202033C2989005 @default.
- W36202033 hasConceptScore W36202033C71924100 @default.
- W36202033 hasLocation W362020331 @default.
- W36202033 hasOpenAccess W36202033 @default.
- W36202033 hasPrimaryLocation W362020331 @default.
- W36202033 hasRelatedWork W1982345091 @default.
- W36202033 hasRelatedWork W2034356835 @default.
- W36202033 hasRelatedWork W2165734445 @default.
- W36202033 hasRelatedWork W2268977368 @default.
- W36202033 hasRelatedWork W2343197344 @default.
- W36202033 hasRelatedWork W2388625303 @default.
- W36202033 hasRelatedWork W2628094801 @default.
- W36202033 hasRelatedWork W2766503583 @default.
- W36202033 hasRelatedWork W2931979449 @default.
- W36202033 hasRelatedWork W2939133296 @default.
- W36202033 hasRelatedWork W3005052620 @default.
- W36202033 hasRelatedWork W3031330541 @default.
- W36202033 hasRelatedWork W3087496550 @default.
- W36202033 hasRelatedWork W3108752302 @default.
- W36202033 hasRelatedWork W3110573513 @default.
- W36202033 hasRelatedWork W3111455697 @default.
- W36202033 hasRelatedWork W3154858853 @default.
- W36202033 hasRelatedWork W3166464412 @default.
- W36202033 hasRelatedWork W3167759437 @default.
- W36202033 hasRelatedWork W2604514228 @default.
- W36202033 hasVolume "52" @default.
- W36202033 isParatext "false" @default.
- W36202033 isRetracted "false" @default.
- W36202033 magId "36202033" @default.
- W36202033 workType "article" @default.